Comparative, double-blind, controlled study of intra-articular hyaluronic acid (Hyalubrix®) injections versus local anesthetic in osteoarthritis of the hip A Migliore, U Massafra, E Bizzi, F Vacca, S Martin-Martin, M Granata, ... Arthritis research & therapy 11, 1-8, 2009 | 92 | 2009 |
Socioeconomic burden of total joint arthroplasty for symptomatic hip and knee osteoarthritis in the Italian population: a 5‐year analysis based on hospitalization records P Piscitelli, G Iolascon, G Di Tanna, E Bizzi, G Chitano, A Argentiero, ... Arthritis care & research 64 (9), 1320-1327, 2012 | 91 | 2012 |
Viscosupplementation in the management of ankle osteoarthritis: a review A Migliore, F Giovannangeli, E Bizzi, U Massafra, A Alimonti, B Laganą, ... Archives of orthopaedic and trauma surgery 131, 139-147, 2011 | 83 | 2011 |
High levels of NK cells in the peripheral blood of patients affected with anti-phospholipid syndrome and recurrent spontaneous abortion: a potential new hypothesis C Perricone, C De Carolis, R Giacomelli, G Zaccari, P Cipriani, E Bizzi, ... Rheumatology 46 (10), 1574-1578, 2007 | 82 | 2007 |
A double blind randomized active-controlled clinical trial on the intra-articular use of Md-Knee versus sodium hyaluronate in patients with knee osteoarthritis (“Joint”) LS Martin Martin, U Massafra, E Bizzi, A Migliore BMC Musculoskeletal Disorders 17, 1-8, 2016 | 69 | 2016 |
Intra-articular injection of hyaluronic acid (MW 1,500–2,000 kDa; HyalOne®) in symptomatic osteoarthritis of the hip: a prospective cohort study M Alberto, M Umberto, B Emanuele, L Bruno, G Valentina, P Prisco, ... Archives of orthopaedic and trauma surgery 131, 1677-1685, 2011 | 67 | 2011 |
Hip viscosupplementation under ultra-sound guidance riduces NSAID consumption in symptomatic hip osteoarthritis patients in a long follow-up. Data from Italian registry. A Migliore, M Granata, S Tormenta, B Lagana, P Piscitelli, E Bizzi, ... European Review for Medical & Pharmacological Sciences 15 (1), 2011 | 66 | 2011 |
The discrepancy between recommendations and clinical practice for viscosupplementation in osteoarthritis: mind the gap! A Migliore, E Bizzi, J Herrero-Beaumont, RJ Petrella, R Raman, ... European Review for Medical & Pharmacological Sciences 19 (7), 2015 | 63 | 2015 |
Total hip replacement rate in a cohort of patients affected by symptomatic hip osteoarthritis following intra-articular sodium hyaluronate (MW 1,500–2,000 kDa) ORTOBRIX study A Migliore, A Bella, M Bisignani, M Calderaro, D De Amicis, G Logroscino, ... Clinical rheumatology 31, 1187-1196, 2012 | 57 | 2012 |
An update on the up and coming therapies to treat osteoarthritis, a multifaceted disease JA Roman-Blas, E Bizzi, R Largo, A Migliore, G Herrero-Beaumont Expert opinion on pharmacotherapy 17 (13), 1745-1756, 2016 | 56 | 2016 |
The safety of anti-TNF agents in the elderly A Migliore, E Bizzi, B Lagana, L Altomonte, G Zaccari, M Granata, ... International Journal of Immunopathology and Pharmacology 22 (2), 415-426, 2009 | 50 | 2009 |
The impact of treatment with hylan GF 20 on progression to total hip arthroplasty in patients with symptomatic hip OA: a retrospective study A Migliore, E Bizzi, U Massafra, A Bella, P Piscitelli, B Lagana, ... Current Medical Research and Opinion 28 (5), 755-760, 2012 | 45 | 2012 |
Intra-articular administration of hylan GF 20 in patients with symptomatic hip osteoarthritis: tolerability and effectiveness in a large cohort study in clinical practice A Migliore, S Tormenta, U Massafra, E Bizzi, F Iannessi, A Alimonti, ... Current medical research and opinion 24 (5), 1309-1316, 2008 | 45 | 2008 |
Safety of intra-articular hip injection of hyaluronic acid products by ultrasound guidance: an open study from ANTIAGE register. A Migliore, S Tormenta, B Lagana, P Piscitelli, M Granata, E Bizzi, ... European Review for Medical & Pharmacological Sciences 17 (13), 2013 | 44 | 2013 |
Immunomodulating therapies in acute myocarditis and recurrent/acute pericarditis E Ammirati, E Bizzi, G Veronese, M Groh, CM Van de Heyning, ... Frontiers in medicine 9, 838564, 2022 | 43 | 2022 |
A new technical contribution for ultrasound-guided injections of sacro-iliac joints A Migliore, E Bizzi, U Massafra, F Vacca, LS Martin-Martin, M Granata, ... Eur Rev Med Pharmacol Sci 14 (5), 465-9, 2010 | 39 | 2010 |
The challenge of the definition of early symptomatic knee osteoarthritis: a proposal of criteria and red flags from an international initiative promoted by the Italian Society … A Migliore, CA Scirč, L Carmona, GH Beaumont, E Bizzi, J Branco, ... Rheumatology international 37, 1227-1236, 2017 | 37 | 2017 |
Interstitial lung disease in rheumatoid arthritis in the era of biologics A Picchianti Diamanti, V Germano, E Bizzi, B Lagana, A Migliore Pulmonary Medicine 2011 (1), 931342, 2011 | 37 | 2011 |
An open randomized active-controlled clinical trial with low-dose SKA cytokines versus DMARDs evaluating low disease activity maintenance in patients with rheumatoid arthritis LS Martin-Martin, F Giovannangeli, E Bizzi, U Massafra, E Ballanti, ... Drug design, development and therapy, 985-994, 2017 | 34 | 2017 |
Indirect comparison of the effects of anti-TNF biological agents in patients with ankylosing spondylitis by means of a mixed treatment comparison performed on efficacy data … A Migliore, S Broccoli, E Bizzi, B Lagana Journal of Medical Economics 15 (3), 473-480, 2012 | 34 | 2012 |